- Home
- FDUS vs SEPN Comparison
FDUS vs SEPN Comparison
Compare FDUS & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDUS
- SEPN
- Stock Information
- Founded
- FDUS 2011
- SEPN 2022
- Country
- FDUS United States
- SEPN United States
- Employees
- FDUS N/A
- SEPN N/A
- Industry
- FDUS Finance/Investors Services
- SEPN
- Sector
- FDUS Finance
- SEPN
- Exchange
- FDUS Nasdaq
- SEPN NYSE
- Market Cap
- FDUS 649.1M
- SEPN 631.0M
- IPO Year
- FDUS 2011
- SEPN 2024
- Fundamental
- Price
- FDUS $18.55
- SEPN $5.90
- Analyst Decision
- FDUS Hold
- SEPN Buy
- Analyst Count
- FDUS 1
- SEPN 4
- Target Price
- FDUS $20.00
- SEPN $33.00
- AVG Volume (30 Days)
- FDUS 325.0K
- SEPN 257.0K
- Earning Date
- FDUS 05-01-2025
- SEPN 05-15-2025
- Dividend Yield
- FDUS 12.66%
- SEPN N/A
- EPS Growth
- FDUS N/A
- SEPN N/A
- EPS
- FDUS 2.40
- SEPN N/A
- Revenue
- FDUS $146,154,000.00
- SEPN $1,075,000.00
- Revenue This Year
- FDUS $2.37
- SEPN N/A
- Revenue Next Year
- FDUS $7.45
- SEPN N/A
- P/E Ratio
- FDUS $7.72
- SEPN N/A
- Revenue Growth
- FDUS 12.33
- SEPN 611.92
- 52 Week Low
- FDUS $16.70
- SEPN $4.17
- 52 Week High
- FDUS $23.55
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- FDUS 39.33
- SEPN N/A
- Support Level
- FDUS $17.33
- SEPN N/A
- Resistance Level
- FDUS $18.82
- SEPN N/A
- Average True Range (ATR)
- FDUS 0.81
- SEPN 0.00
- MACD
- FDUS -0.01
- SEPN 0.00
- Stochastic Oscillator
- FDUS 46.72
- SEPN 0.00
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.